| Name | 4-({Benzyl[(8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazol-3-yl)carbonyl]amino}methyl)benzoic acid |
|---|---|
| Synonyms |
inhibit,Inhibitor,Autophagy,NR1H4,FXR,Nidufexor,LMB-763,LMB763,LMB
Benzoic acid, 4-[[[(8-chloro-1,4-dihydro-1-methylbenzopyrano[4,3-c]pyrazol-3-yl)carbonyl](phenylmethyl)amino]methyl] (Nidufexor)EOS-61760 Nidufexor, 10 mM in DMSO Nidufexor(LMB-763) EOS-61760 4-((N-benzyl-8-chloro-1-methyl-1,4-dihydrochromeno[4,3-c]pyrazole-3-cboxamido)methyl)benzoicacid LMB-763 |
| Description | Nidufexor is a farnesoid X receptor (FXR) agonist[1]. |
|---|---|
| Related Catalog | |
| Target |
FXR[1] |
| References |
[1]. Proposed INN: List 118. WHO Drug Information, Vol. 31, No. 4, 2017. |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 781.1±60.0 °C at 760 mmHg |
| Molecular Formula | C27H22ClN3O4 |
| Molecular Weight | 487.93 |
| Flash Point | 426.2±32.9 °C |
| Exact Mass | 487.129883 |
| LogP | 3.72 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.671 |
| Storage condition | 2-8℃ |